Biogen discontinues Apellis programs post $5.6B acquisition, reallocating resources to Empaveli and Syfovre. U.S. begins ...
The American Kidney Fund (AKF) has launched a series of new resources for kidney transplant patients and their loved ones that explains the complex kidney transplant process, including recovery, ...
Satellos Bioscience Inc. ("Satellos" or the "Company"), a clinical-stage biotechnology company developing novel therapies to treat degenerative muscle diseases, today announced that the U.S. Food and ...
Deutsche Börse Scale Summit June 23, 2026 6:30 AM EDTCompany ParticipantsPascal Klein - Chairman of the Executive Board ...
Biogen scales back Apellis programs, trims research roles after $5.6 billion buyout Biogen said on Friday it had either paused or discontinued funding for most of Apellis Pharmaceuticals' research ...
TG Therapeutics, Inc. boosts anti-CD20 share as Q1 revenue jumps 69.6% to $204.9M, but overbought signals hint at a near-term ...
Biogen has decided to advance its tau-targeting Alzheimer's disease drug diranersen (BIIB080) into a phase 3 trial programme, despite a phase 2 trial missing its main efficacy measure. In the 18-month ...
Mobile terminals will no longer be containers for installing applications but will turn into a stage for artificial ...
Ionis Pharmaceuticals, Inc. today announced that it has entered into a license agreement with Recordati ("Recordati"), under which Recordati obtained exclusive rights to develop and commercialize ...
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, ...
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, ...
Biocon is integrating artificial intelligence gradually across drug discovery and manufacturing processes. The company employs a two-track approach: AI for Enterprise enhances productivity, while AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results